Substance abuse treatment denial lawsuits are civil cases in which patients, families, and treatment providers sue insurance companies for refusing to cover necessary addiction treatment services. These lawsuits allege that insurers violated insurance contracts and federal law by improperly denying or delaying coverage for inpatient rehabilitation, residential treatment, counseling, medications, and other evidence-based services. In recent years, dozens of such cases have resulted in significant settlements, including a $12.88 million settlement with Anthem Inc. covering approximately 18,756 members whose treatment claims were denied between April 2017 and April 2025.
The core issue underlying these lawsuits is straightforward: people struggling with addiction are being blocked from the treatment they need because their insurance companies say no. A research study surveying 3,000 mental health and substance abuse consumers and family members found that denials for substance use disorder treatment occur far more frequently than denials for other medical care. This pattern of denials contradicts the Mental Health Parity and Addiction Equality Act of 2013, federal law that makes it illegal to deny coverage for inpatient treatment of substance abuse and mental health issues. Yet insurance denials continue, and when they do, the financial and health consequences can be severe.
Table of Contents
- What Types of Treatment Are Being Denied?
- How Insurance Companies Deny Treatment Claims
- Major Settlements and Their Outcomes
- Federal Law Protects Substance Abuse Treatment Coverage
- Common Denial Patterns and Red Flags
- Medication Access and Non-Discrimination
- Current Litigation and What It Means Going Forward
- Conclusion
What Types of Treatment Are Being Denied?
insurance companies have denied coverage for a wide range of addiction treatment services. Residential rehabilitation programs, inpatient detoxification, intensive outpatient programs, and specialized therapies have all been subjects of lawsuits. In the United Behavioral health settlement, the insurance company denied a plaintiff’s request for equine therapy as part of her substance abuse treatment, claiming it was “experimental, investigational or unproven.” The denial violated federal parity law, yet the insurer did not cover the treatment until after the case was litigated.
Another pattern involves medication-assisted treatment. The Salvation Army class action lawsuit, which received approval to proceed as a class action on March 26, 2025, challenges a recovery housing program’s policy of disallowing addiction medications like buprenorphine. Buprenorphine is an FDA-approved medication with strong clinical evidence supporting its use in substance abuse treatment. By prohibiting residents from using this medication, the program created a barrier that contradicted both medical best practices and legal protections for people with addiction.
How Insurance Companies Deny Treatment Claims
Insurance companies employ several methods to deny or delay substance abuse treatment coverage. Some use automated decision-making tools without human review of medical necessity. Others conduct what are called “utilization reviews”—assessments of whether a treatment is medically necessary—but conduct them in ways that are inconsistent with medical standards or parity requirements. UnitedHealthcare and Cigna Healthcare both face lawsuits alleging that they used automated data tools to wrongfully deny medical claims without adequate human oversight or medical expertise.
A significant limitation of these denial processes is that they often occur without input from the treating physician or the patient’s medical records. Insurance companies may also deny claims by claiming a treatment is experimental or investigational, even when the treatment is FDA-approved and widely recognized in the medical community. In the Anthem v. treatment centers litigation filed in September 2023, a treatment center operator alleged that Anthem used punitive measures against facilities for having staff appeal coverage denials on behalf of patients. This dynamic creates a chilling effect: treatment centers learn that advocating for patients results in retaliation, so they may stop fighting denials even when coverage should be granted.
Major Settlements and Their Outcomes
The Anthem settlement represents one of the largest recent judgments in substance abuse treatment denial litigation. Anthem paid $12.88 million to settle allegations that it improperly denied residential treatment coverage. The settlement class includes all Anthem members whose residential treatment claims were denied during an eight-year period from April 29, 2017 through April 30, 2025.
The claim deadline was January 20, 2026, and affected members could receive compensation for out-of-pocket costs, the cost of treatment they received without insurance, or other damages. Another significant settlement came from United Health, which paid $15.6 million in August 2021 after being sued for unlawfully denying addiction treatment coverage to thousands of patients. The United Behavioral Health settlement also resolved a major case, paying $1.4 million or more to settle allegations of illegal denial of coverage for mental health and substance abuse treatment services. These settlements do not undo the harm—patients were still denied coverage when they needed it most—but they provide financial recovery and establish that insurance companies’ denials violated the law.
Federal Law Protects Substance Abuse Treatment Coverage
The Mental Health Parity and Addiction Equality Act of 2013 is the primary federal law protecting people with substance use disorders. This law makes it illegal for health insurance companies to deny coverage for inpatient treatment of addiction on the grounds that it is less necessary than coverage for other medical conditions. In plain language, if an insurance plan covers inpatient treatment for a broken leg or infection, it must also cover inpatient treatment for substance abuse disorder.
The law also requires that insurance companies apply the same standards when reviewing mental health and substance abuse claims as they do when reviewing other medical claims. A comparison illustrates the tradeoff: before the parity law, an insurance company might deny inpatient addiction treatment as “experimental” while covering inpatient cardiac surgery without question. The law levels the playing field by requiring equal treatment, but enforcement remains weak. Insurance companies continue to deny claims, often counting on patients to be too sick, desperate, or unfamiliar with their legal rights to fight back.
Common Denial Patterns and Red Flags
Several denial patterns appear repeatedly in lawsuits. Insurance companies deny claims for “lack of medical necessity,” even when the claim is for treatment recommended by a board-certified addiction medicine physician. They deny coverage for longer stays in residential treatment, claiming that a shorter stay would be sufficient, despite evidence that longer stays produce better outcomes. They also deny claims based on administrative reasons—such as requiring prior authorization that arrives after treatment has begun—which effectively prevents coverage.
A critical warning: if you receive a treatment denial, do not assume the insurance company is correct. Many denials are improper under federal law. Insurance companies routinely deny claims that should be covered, relying on the fact that many patients will not appeal or will be unable to appeal while in active treatment. Treatment centers and patient advocates report that appeals often succeed when patients have the knowledge and resources to pursue them. However, the burden of fighting denials falls on the patient or treatment provider, not the insurance company.
Medication Access and Non-Discrimination
One emerging area in substance abuse treatment denial litigation concerns medication access. The Salvation Army case specifically challenges policies that exclude FDA-approved addiction medications. Some treatment programs, halfway houses, and recovery facilities have historically prohibited residents from taking medications like buprenorphine, methadone, or naltrexone, even though these medications are scientifically proven to reduce cravings and prevent relapse.
This creates a harm that extends beyond insurance denials. Even when a patient has insurance coverage for medication-assisted treatment, they may be unable to access it if they are living in a recovery housing program that prohibits such medications. The class action lawsuit filed on March 26, 2025 challenges this contradiction and asserts that excluding medication amounts to disability discrimination and violation of federal law. This represents a shift in litigation strategy: rather than only suing insurers for denying coverage, advocates are also suing treatment providers and housing programs for denying access.
Current Litigation and What It Means Going Forward
Multiple lawsuits are currently moving through the courts. The Salvation Army case demonstrates that courts are willing to allow addiction medication access cases to proceed to trial. UnitedHealthcare and Cigna Healthcare face ongoing litigation over automated denial systems. These cases signal that judges recognize substance abuse treatment denial as a serious legal problem, not merely an insurance industry practice.
The trend suggests that courts will continue to scrutinize insurance company denial practices and hold companies accountable when those practices violate parity law. Insurance companies are also facing increased pressure from regulators and lawmakers to improve their review processes for mental health and addiction treatment claims. However, change is gradual, and thousands of people are still being denied coverage while litigation proceeds. If you are denied treatment coverage, the fact that these lawsuits exist and succeed means you have legal grounds to appeal and potentially sue.
Conclusion
Substance abuse treatment denial lawsuits address a critical gap between what the law requires and what insurance companies actually do. Federal law prohibits discrimination against people with substance use disorders, yet insurance companies continue to deny coverage for evidence-based treatments. Recent settlements—including the $12.88 million Anthem settlement and the $15.6 million United Health settlement—have provided financial recovery to thousands of affected members and established that these denials are illegal. If your substance abuse treatment claim has been denied, you have options.
You can appeal the decision, often with assistance from your treatment provider or an advocate. You can also investigate whether the denial might be part of a larger class action lawsuit, which could entitle you to compensation without filing an individual suit. Contact your state insurance commissioner’s office or an attorney specializing in insurance disputes if you believe your denial was improper. The law is on your side, even if the insurance company’s initial decision was not.